HIGHLIGHTS
- who: Bin Guo from the Foundation (IRCCS), Italy University of Science and Technology of have published the research: Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects, in the Journal: (JOURNAL)
- how: Many important ongoing studies are presented in Table 2 so keep an eye on the results of these studies and look forward to taking postoperative adjuvant therapy to the next level.
- future: The combination of PD-1 inhibitors and interferon is promising both in the treatment of advanced HCC and in adjuvant therapy after radical surgery and more . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.